Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124913172 | 12491317 | 2 | F | 20150628 | 20160621 | 20160623 | 20160705 | EXP | DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-118816 | RANBAXY | 87.00 | YR | F | Y | 0.00000 | 20160705 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124913172 | 12491317 | 1 | PS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, DAILY | U | 73137 | 50 | MG | |||||||
| 124913172 | 12491317 | 2 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY | U | 73137 | 75 | MG | |||||||
| 124913172 | 12491317 | 3 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 2 MG, DAILY | U | 0 | 2 | MG | |||||||
| 124913172 | 12491317 | 4 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 2.5 MG, DAILY | U | 0 | 2.5 | MG | |||||||
| 124913172 | 12491317 | 5 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 3.5 MG, DAILY | U | 0 | 3.5 | MG | |||||||
| 124913172 | 12491317 | 6 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 4 MG, DAILY | U | 0 | 4 | MG | |||||||
| 124913172 | 12491317 | 7 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 3 MG, DAILY | U | 0 | 3 | MG | |||||||
| 124913172 | 12491317 | 8 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 4 MG, DAILY | U | 0 | 4 | MG | |||||||
| 124913172 | 12491317 | 9 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 3 MG, DAILY | U | 0 | 3 | MG | |||||||
| 124913172 | 12491317 | 10 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 3.5 MG, DAILY | U | 0 | 3.5 | MG | |||||||
| 124913172 | 12491317 | 11 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 2 MG, DAILY | U | 0 | 2 | MG | |||||||
| 124913172 | 12491317 | 12 | SS | Bisoprolol | BISOPROLOL | 1 | Oral | 10 MG, DAILY | U | 0 | 10 | MG | |||||||
| 124913172 | 12491317 | 13 | SS | Melperon | MELPERONE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | ||||||||
| 124913172 | 12491317 | 14 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, DAILY | U | 0 | 20 | MG | |||||||
| 124913172 | 12491317 | 15 | SS | Ciatyl | CLOPENTHIXOL HYDROCHLORIDE | 1 | Oral | 2 MG, DAILY | U | U | 0 | 2 | MG | ||||||
| 124913172 | 12491317 | 16 | SS | Ciatyl | CLOPENTHIXOL HYDROCHLORIDE | 1 | Oral | 3 MG, DAILY | U | 0 | 3 | MG | |||||||
| 124913172 | 12491317 | 17 | C | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Oral | 20 MG, DAILY | U | 0 | 20 | MG | |||||||
| 124913172 | 12491317 | 18 | C | Novaminsulfon | METAMIZOLE | 1 | Oral | 2000 MG, DAILY | U | 0 | 2000 | MG | |||||||
| 124913172 | 12491317 | 19 | C | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, DAILY | U | N | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124913172 | 12491317 | 1 | Restlessness |
| 124913172 | 12491317 | 2 | Restlessness |
| 124913172 | 12491317 | 3 | Product used for unknown indication |
| 124913172 | 12491317 | 4 | Product used for unknown indication |
| 124913172 | 12491317 | 5 | Product used for unknown indication |
| 124913172 | 12491317 | 6 | Product used for unknown indication |
| 124913172 | 12491317 | 7 | Product used for unknown indication |
| 124913172 | 12491317 | 8 | Product used for unknown indication |
| 124913172 | 12491317 | 9 | Product used for unknown indication |
| 124913172 | 12491317 | 10 | Product used for unknown indication |
| 124913172 | 12491317 | 11 | Product used for unknown indication |
| 124913172 | 12491317 | 12 | Product used for unknown indication |
| 124913172 | 12491317 | 13 | Product used for unknown indication |
| 124913172 | 12491317 | 14 | Product used for unknown indication |
| 124913172 | 12491317 | 15 | Restlessness |
| 124913172 | 12491317 | 16 | Restlessness |
| 124913172 | 12491317 | 17 | Product used for unknown indication |
| 124913172 | 12491317 | 18 | Product used for unknown indication |
| 124913172 | 12491317 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124913172 | 12491317 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124913172 | 12491317 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124913172 | 12491317 | 1 | 20150623 | 20150701 | 0 | |
| 124913172 | 12491317 | 2 | 20150702 | 0 | ||
| 124913172 | 12491317 | 3 | 20150610 | 20150616 | 0 | |
| 124913172 | 12491317 | 4 | 20150617 | 20150622 | 0 | |
| 124913172 | 12491317 | 5 | 20150623 | 0 | ||
| 124913172 | 12491317 | 6 | 20150624 | 0 | ||
| 124913172 | 12491317 | 7 | 20150625 | 20150626 | 0 | |
| 124913172 | 12491317 | 8 | 20150627 | 20150628 | 0 | |
| 124913172 | 12491317 | 9 | 20150629 | 20150630 | 0 | |
| 124913172 | 12491317 | 10 | 20150701 | 0 | ||
| 124913172 | 12491317 | 11 | 20150702 | 0 | ||
| 124913172 | 12491317 | 12 | 2013 | 0 | ||
| 124913172 | 12491317 | 13 | 2014 | 20150702 | 0 | |
| 124913172 | 12491317 | 14 | 2013 | 0 | ||
| 124913172 | 12491317 | 15 | 20150623 | 20150701 | 0 | |
| 124913172 | 12491317 | 16 | 20150702 | 0 | ||
| 124913172 | 12491317 | 17 | 20130403 | 20150702 | 0 | |
| 124913172 | 12491317 | 18 | 2014 | 20150702 | 0 | |
| 124913172 | 12491317 | 19 | 20130226 | 20150702 | 0 |